Immunogenicity of enhanced potency inactivated polio vaccine.
dc.contributor.author | Singh, J | en_US |
dc.contributor.author | Ravi, R N | en_US |
dc.contributor.author | Dutta, A K | en_US |
dc.contributor.author | Kumari, S | en_US |
dc.contributor.author | Khare, S | en_US |
dc.date.accessioned | 1992-11-01 | en_US |
dc.date.accessioned | 2009-05-27T05:37:16Z | |
dc.date.available | 1992-11-01 | en_US |
dc.date.available | 2009-05-27T05:37:16Z | |
dc.date.issued | 1992-11-01 | en_US |
dc.description.abstract | Fifty two children were immunized with two doses of enhanced potency inactivated polio vaccine in order to determine its efficacy. The vaccine was very efficacious with 92.3, 92.3 and 88.3% of the children seroconverting to the three poliovirus types, respectively. The vaccine was equally efficacious whether the two doses were given at 4-week or 8-week intervals or when immunization was started at 6-7 weeks of age or later. The presence of maternal antibodies did not interfere significantly with the seroresponse to two doses of IPV-E. The study recommends that two doses of IPV-E give satisfactory seroconversion rates. Immunization can be started as early as 6 weeks age and the two doses can be given at 4 weeks interval to complete primary immunization against poliomyelitis. | en_US |
dc.description.affiliation | Department of Pediatrics, Lady Hardinge Medical College, New Delhi. | en_US |
dc.identifier.citation | Singh J, Ravi RN, Dutta AK, Kumari S, Khare S. Immunogenicity of enhanced potency inactivated polio vaccine. Indian Pediatrics. 1992 Nov; 29(11): 1353-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/12097 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://indianpediatrics.net | en_US |
dc.subject.mesh | Antibodies, Viral --blood | en_US |
dc.subject.mesh | Dose-Response Relationship, Immunologic | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunization Schedule | en_US |
dc.subject.mesh | Infant | en_US |
dc.subject.mesh | Poliomyelitis --prevention & control | en_US |
dc.subject.mesh | Poliovirus --immunology | en_US |
dc.subject.mesh | Poliovirus Vaccine, Inactivated --immunology | en_US |
dc.title | Immunogenicity of enhanced potency inactivated polio vaccine. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1